(Q37143633)

18 August 2017

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes (English)

1 reference

18 August 2017

1 reference

3

Michael Boeckh

1 reference

18 August 2017

13

Rainer Storb

1 reference

18 August 2017

2

Barry E Storer

1 reference

18 August 2017

Frederick R. Appelbaum

series ordinal

14

object named as

Frederick R Appelbaum

1 reference

18 August 2017

1

Marco Mielcarek

1 reference

18 August 2017

6

H Joachim Deeg

1 reference

18 August 2017

15

Paul J Martin

1 reference

18 August 2017

9

Kristine Doney

1 reference

18 August 2017

12

Terry Furlong

1 reference

18 August 2017

11

Kieren A Marr

1 reference

18 August 2017

10

Stephanie Lee

1 reference

18 August 2017

8

Mary E D Flowers

1 reference

18 August 2017

Paul A Carpenter

4

1 reference

18 August 2017

George B McDonald

series ordinal

5

1 reference

18 August 2017

Richard A Nash

series ordinal

7

1 reference

18 August 2017

language of work or name

English

0 references

publication date

10 November 2008

1 reference

18 August 2017

1 reference

18 August 2017

113

1 reference

18 August 2017

13

1 reference

18 August 2017

2888-2894

1 reference

Graft-versus-host disease

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

1994 Consensus Conference on Acute GVHD Grading

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

Acute graft-versus-host disease following unrelated donor marrow transplantation: failure of conventional therapy

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

High-dose methylprednisolone therapy for acute graft-versus-host disease associated with matched unrelated donor bone marrow transplantation

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662636

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

3 September 2018

1 reference

12 December 2020

Response of graft versus host disease to high doses of methyl prednisolone

1 reference

12 December 2020

High dose bolus methylprednisolone for the treatment of acute graft versus host disease

1 reference

12 December 2020

High-dose methylprednisolone treatment for acute graft-versus-host disease after bone marrow transplantation in adults

1 reference

12 December 2020

Risk of infectious complications in patients taking glucocorticosteroids

1 reference

12 December 2020

A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment

1 reference

12 December 2020

Treatment of moderate and severe acute GVHD after allogeneic bone marrow transplantation

1 reference

12 December 2020

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1 reference

12 December 2020

Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial

1 reference

12 December 2020

Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients

1 reference

12 December 2020

10.1182/BLOOD-2008-07-168401

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19001082

1 reference